Advancing the business from both short- and medium- to long-term perspectives
First written in FY2024-H1. 4 of 5 entries say "Restated". Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1RestatedAnnual report
「As a venture company originating from Keio University School of Medicine, we are advancing research, development and monetization of the iPS drug discovery business and the iPS cell-based regenerative medicine business with an awareness not only of the short term but also of the medium to long term.」
The company reiterates its policy of pursuing research and development and monetization in iPS drug discovery and regenerative medicine from both short-term and medium- to long-term perspectives. - FY2025RestatedAnnual report
「As a venture company originating from Keio University School of Medicine, we are advancing research, development and monetization of the iPS drug discovery business and the iPS cell-based regenerative medicine business with an awareness not only of the short term but also of the medium to long term.」
The company reiterates its policy of pursuing research and development and monetization in iPS drug discovery and regenerative medicine from both short-term and medium- to long-term perspectives. - FY2025-H1RestatedAnnual report
「As a venture company originating from Keio University School of Medicine, we are advancing research, development and monetization of the iPS drug discovery business and the iPS cell-based regenerative medicine business with an awareness not only of the short term but also of the medium to long term.」
The company reiterates its policy of pursuing research and development and monetization in iPS drug discovery and regenerative medicine from both short-term and medium- to long-term perspectives. - FY2024RestatedAnnual report
「In this environment, we are advancing our business with an awareness not only of the short term but also of the medium to long term.」
The company reiterates its policy of advancing the business with both short-term and medium- to long-term perspectives. - FY2024-H1First statedAnnual report
「In this environment, we are advancing our business with an awareness not only of the short term but also of the medium to long term.」
The company first explicitly stated its intention to advance the business with both short-term and medium- to long-term perspectives.